# Endometrial Carcinoma

- Malignant tumor arising from **endometrial lining of the uterus**
- Most common **gynecological cancer** in developed countries

## Causes of Postmenopausal Bleeding

> Bleeding from the genital tract **after 12 months of amenorrhoea** in a woman over 45 years (typically postmenopausal).

### Common Causes

1. **Atrophic endometrium/vaginitis** â€“ _(most common cause)_
2. **Endometrial carcinoma**
3. **Endometrial hyperplasia** (with/without atypia)
4. **Cervical cancer**
5. **Hormone replacement therapy (HRT)**
6. **Endometrial or cervical polyp**
7. **Coagulopathy / bleeding disorders**
8. **Urethral caruncle / bladder lesions**
9. **Vaginal trauma or foreign body**
10. **Ovarian estrogen-producing tumors** (e.g., granulosa cell tumor)

## Types

### Type I (Estrogen-dependent)

- Endometrioid adenocarcinoma (80%)
- Associated with **unopposed estrogen** exposure
- Better prognosis

### Type II (Non-estrogen-dependent)

- Serous, clear cell, carcinosarcoma
- Postmenopausal women, atrophic endometrium
- Aggressive, poor prognosis

## Staging â€“ FIGO (Surgical-Pathological Staging)

| Stage   | Description                                      |
| ------- | ------------------------------------------------ |
| **I**   | Tumor confined to uterus                         |
| IA      | \<50% myometrial invasion                        |
| IB      | â‰¥50% myometrial invasion                         |
| **II**  | Cervical stromal involvement (not beyond uterus) |
| **III** | Local/regional spread                            |
| IIIA    | Serosa/adnexa involvement                        |
| IIIB    | Vaginal/parametrium involvement                  |
| IIIC1   | Pelvic LN involvement                            |
| IIIC2   | Para-aortic LN involvement                       |
| **IV**  | Distant spread                                   |
| IVA     | Bladder or bowel mucosa                          |
| IVB     | Distant metastasis (lungs, liver, etc.)          |

## \*Risk Factors

### Unopposed Estrogen Exposure

- Early menarche, late menopause
- Nulliparity
- Estrogen-only HRT
- PCOS (chronic anovulation)
- Obesity (peripheral conversion of androgens â†’ estrogen)

### Medical Conditions

- Diabetes mellitus
- Hypertension
- Breast cancer (especially on **tamoxifen**)

### Genetic

- **Lynch syndrome (HNPCC)** â€“ â†‘ risk of endometrial & colon cancers
- Family history of endometrial cancer

## Clinical Features

### A. Postmenopausal Women

- **Postmenopausal bleeding** (most common symptom)

### B. Perimenopausal Women

- Irregular heavy menstrual bleeding
- Intermenstrual bleeding

### C. Advanced Disease

- Pelvic pain
- Vaginal discharge (watery/bloody)
- Mass or enlarged uterus
- Weight loss, fatigue

## Investigations

### For Diagnosis

1. **Transvaginal Ultrasound (TVS)**

   - **Endometrial thickness >4 mm** â†’ abnormal
   - Heterogeneous, irregular endometrium
   - Best initial test

2. **Endometrial sampling**

   - **Pipelle biopsy** (OPD)
   - If inadequate or suspicious â†’ **Dilatation & Curettage (D\&C)**
   - **Hysteroscopy + biopsy** if focal lesions suspected

### For Staging

1. **MRI pelvis**

   - Assesses depth of **myometrial invasion** and **cervical involvement**

2. **CT scan chest/abdomen/pelvis**

   - Detects lymphadenopathy or metastases

3. **Cystoscopy/sigmoidoscopy**

   - If bladder or rectal invasion suspected

### For Risk Assessment

- Blood glucose, lipid profile, BP â†’ metabolic syndrome
- Family history/genetic testing â†’ **MSI or Lynch syndrome**

## Management

### General Principles

- Based on:

  - **Stage of cancer**
  - **Histological type & grade**
  - **Depth of myometrial invasion**
  - **Lymphovascular involvement**
  - **Patientâ€™s age, comorbidities, fertility desire**

### Contraindications to Primary Surgery

- Distant metastases
- Poor surgical fitness â†’ consider **radiotherapy or hormonal therapy**

### Stage-wise Management (FIGO 2021)

#### Stage I â€“ Tumor confined to uterus

##### IA (Grade 1â€“2, \<50% myometrial invasion)

- **Total hysterectomy with bilateral salpingo-oophorectomy (TH + BSO)**
- No lymphadenectomy needed if low risk

###### Adjuvant:

- Observe if low risk
- **Vaginal brachytherapy** if intermediate risk

##### IB (â‰¥50% myometrial invasion or Grade 3)

- TH + BSO + **Pelvic Â± para-aortic lymphadenectomy or sentinel node mapping**
- **Adjuvant radiotherapy** (EBRT Â± vaginal brachytherapy)

---

#### Stage II â€“ Cervical stromal invasion

- **Radical hysterectomy + BSO + pelvic Â± para-aortic lymphadenectomy**
- **Adjuvant EBRT Â± brachytherapy**

---

#### Stage III â€“ Local/regional spread

##### ðŸ”¹ IIIA â€“ Serosa/adnexa

##### ðŸ”¹ IIIB â€“ Vagina/parametrium

##### ðŸ”¹ IIIC â€“ Pelvic/para-aortic nodes

- **TH + BSO + pelvic/para-aortic lymphadenectomy**
- **Tumor debulking if extra-uterine disease**
- âž• **Adjuvant chemoradiotherapy**:

  - **EBRT + cisplatin-based chemotherapy**

---

#### Stage IV â€“ Distant metastasis

##### ðŸ”¹ IVA â€“ Bladder/bowel invasion

##### ðŸ”¹ IVB â€“ Distant mets (lung, liver)

- **Not curable**, aim: palliation
- **Primary treatment**:

  - **Progestin-based hormonal therapy** (if ER/PR +ve)
  - Or **chemotherapy** (Carboplatin + Paclitaxel)

- Palliative **radiotherapy** for bleeding or pain

### Fertility-Sparing Treatment (Selected IA Grade 1 Only)

#### Indications:

- Strong fertility desire
- Age \<40, Stage IA, Grade 1, no myometrial invasion
- ER/PR positive tumors

#### Treatment:

- **High-dose progestins**: Medroxyprogesterone acetate or megestrol acetate
- Or **LNG-IUS (Levonorgestrel IUD)**
- Regular endometrial sampling every 3â€“6 months
- Definitive **hysterectomy** after childbearing

### Adjuvant Therapies Summary

| **Risk**                    | **Adjuvant Treatment**              |
| --------------------------- | ----------------------------------- |
| Low (Stage IA, G1â€“2)        | Observe                             |
| Intermediate                | Vaginal brachytherapy               |
| High-intermediate           | EBRT Â± brachytherapy                |
| High (Stage IB, G3 or LVSI) | EBRT + chemo                        |
| Advanced                    | Chemoradiotherapy Â± palliative care |

### Complications of Treatment

#### Surgery

- Bleeding, infection, DVT/PE
- Ureteric or bowel injury
- Lymphedema (if lymphadenectomy)

#### Radiotherapy

- Vaginal stenosis, atrophy
- Radiation cystitis or proctitis
- Bowel obstruction

#### Chemotherapy

- Neutropenia, fatigue
- Neuropathy
- GI upset, alopecia
